Sickle Cell Disease: Past, Present, Future, and Gene therapy

Sickle cell disease is the most common genetic hemoglobin disorder. Although the molecular basis of the sickle cell disease has been known 75 years ago, majority of patients are still suffering from serious complications of this disease due to paucity of effective therapy. And the life expectancy of sickle cell patients is barely 50 years.
Thanks to research scientist, now new gene therapies were invented, which provide great hope for the suffering sickle disease patients.